Search research articles
Contact Us
Filters
Showing results (451-460 of 473) with videos related to
Page
of 48
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors
Muhammad Wasif Saif, Chris Takimoto, Monica Mita, et al.
Cancer Chemotherapy and Pharmacology
|
May 6, 2009
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer
Muhammad Wasif Saif, K I Syrigos, S Hotchkiss, et al.
International Archives of Allergy and Immunology
|
July 2, 2011
Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol
Ekaterini Syrigou, Ioannis Dannos, Elias Kotteas, et al.
Cancer Medicine Journal
|
August 9, 2021
The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells
Muhammad Wasif Saif, Shrikar Rajagopal, Jennifer Caplain, et al.
Translational Gastroenterology and Hepatology
|
March 4, 2022
Rectal Dieulafoy's lesion: a comprehensive review of patient characteristics, presentation patterns, diagnosis, management, and clinical outcomes
Faisal Inayat, Amna Hussain, Sidra Yahya, et al.
JOP : Journal of the Pancreas
|
March 9, 2010
Management of skin toxicities of anti-EGFR agents in patients with pancreatic cancer and other GI tumors by using electronic communication: effective and convenient
Muhammad Wasif Saif, Kristin Kaley, Lynne Lamb, et al.
British Journal of Clinical Pharmacology
|
January 11, 2019
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment
Muhammad Wasif Saif, Lee Rosen, Michelle A Rudek, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2013
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
Muhammad Wasif Saif, Jia Li, Lynne Lamb, et al.
Cancer Journal (Sudbury, Mass.)
|
August 13, 2009
Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas
Muhammad Wasif Saif, H Oettle, W L Vervenne, et al.
JOP : Journal of the Pancreas
|
February 28, 2020
Simplified/Same Day(s)-GOLF as First-line Treatment of Metastatic Carcinoma of Unknown Primary (CUP), Suggestive of Pancreatobiliary Tumors
Muhammad Wasif Saif, Komal Wasif, Martin D Goodman, et al.
Page
of 48
Search research articles
Search
Showing results (451-460 of 473) with videos related to
Sort By:
Page
of 48
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 8, 2013
A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors
Muhammad Wasif Saif, Chris Takimoto, Monica Mita, et al.
Cancer Chemotherapy and Pharmacology
|
May 6, 2009
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer
Muhammad Wasif Saif, K I Syrigos, S Hotchkiss, et al.
International Archives of Allergy and Immunology
|
July 2, 2011
Hypersensitivity reactions to docetaxel: retrospective evaluation and development of a desensitization protocol
Ekaterini Syrigou, Ioannis Dannos, Elias Kotteas, et al.
Cancer Medicine Journal
|
August 9, 2021
The First Study Evaluating the Safety of Pre-Surgery Administration of Metformin in Patients with Colorectal and other Gastrointestinal Cancers and Effect on Cancer Stem Cells
Muhammad Wasif Saif, Shrikar Rajagopal, Jennifer Caplain, et al.
Translational Gastroenterology and Hepatology
|
March 4, 2022
Rectal Dieulafoy's lesion: a comprehensive review of patient characteristics, presentation patterns, diagnosis, management, and clinical outcomes
Faisal Inayat, Amna Hussain, Sidra Yahya, et al.
JOP : Journal of the Pancreas
|
March 9, 2010
Management of skin toxicities of anti-EGFR agents in patients with pancreatic cancer and other GI tumors by using electronic communication: effective and convenient
Muhammad Wasif Saif, Kristin Kaley, Lynne Lamb, et al.
British Journal of Clinical Pharmacology
|
January 11, 2019
Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment
Muhammad Wasif Saif, Lee Rosen, Michelle A Rudek, et al.
Cancer Chemotherapy and Pharmacology
|
December 4, 2013
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
Muhammad Wasif Saif, Jia Li, Lynne Lamb, et al.
Cancer Journal (Sudbury, Mass.)
|
August 13, 2009
Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas
Muhammad Wasif Saif, H Oettle, W L Vervenne, et al.
JOP : Journal of the Pancreas
|
February 28, 2020
Simplified/Same Day(s)-GOLF as First-line Treatment of Metastatic Carcinoma of Unknown Primary (CUP), Suggestive of Pancreatobiliary Tumors
Muhammad Wasif Saif, Komal Wasif, Martin D Goodman, et al.
Page
of 48